title: Treatment of adult hyper-IgD syndrome with canakinumab.
authors.affiliation: Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine, Wexner Medical Center at the Ohio State University, 201 Davis Heart and Lung Research Institute, Columbus, Ohio. Electronic address: Casey.Curtis@osumc.edu.
authors.forename: Casey D
authors.initials: CD
authors.lastname: Curtis
authors.affiliation: Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine, Wexner Medical Center at the Ohio State University, 201 Davis Heart and Lung Research Institute, Columbus, Ohio.
authors.forename: Charity C
authors.initials: CC
authors.lastname: Fox
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D004252:DNA Mutational Analysis; D057210:Delayed Diagnosis; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D053583:Interleukin-1beta / Q000276:immunology; D054078:Mevalonate Kinase Deficiency / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D009154:Mutation / Q000235:genetics; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053583:Interleukin-1beta; C541220:canakinumab; D017853:Phosphotransferases (Alcohol Group Acceptor); C021796:mevalonate kinase